SIRPA and cancer: Since we previously described PPRHs as a gene silencing tool against different cancer targets in different human cell lines [15, 31–33], in this study we designed four different PPRHs to decrease the level of both CD47 and SIRPα and we demonstrated that all PPRHs were able to silence their target at both the mRNA and protein level.